
Health and medicine
Some biotech startups are looking beyond AI-powered drug discovery
STAT’s AI Prognosis newsletter points to biotech startups that believe artificial intelligence could make a greater impact elsewhere than in drug discovery. The material provided does not identify the companies or explain their approaches.


